Picture of Pulmonx logo

LUNG Pulmonx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Pulmonx Corp expected to post a loss of 37 cents a share - Earnings Preview

* Pulmonx Corp  LUNG.OQ   LUNG.O  is expected to show a rise in
quarterly revenue when it reports results on November 2. 
* The Redwood City, California-based company is expected to
report  a 24.2% increase in revenue to $13.178 million from
$10.61 million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Pulmonx Corp is for a
loss of 37 cents per share. For the same quarter last year, the
company reported a loss of $2.26 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Pulmonx Corp is
$54.5​, about 28.6% above​ its last closing price of $38.93. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.37       -0.37      -0.34     Beat    8.6
 Mar. 31 2021  -0.38       -0.38      -0.34     Beat    10.1
 Dec. 31 2020  -0.28       -0.28      -0.27     Beat    2.9​
 Sep. 30 2020  -4.32       -4.32      -2.26     Beat    47.7
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated October 30 at 02:01 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Pulmonx

See all news